Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO)

This study has been completed.

Study NCT00038961 Information provided by GlaxoSmithKline

First Received: June 5, 2002 Last Updated: August 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2004
Primary Completion Date:	October 2004 (Final data collection date for primary outcome measure)